Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

146.73 +0.99 (+0.68%)
Streaming Delayed Price Updated: 11:56 AM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Lucy Scientific Discovery, Inc. Scores Major Milestone, Transitions To Revenue Generating Company With First Commercial Sale Of Psilocybin ($LSDI)
Via AB Newswire
Is Amazon a Blue Chip Stock?
Is Amazon a blue chip stock or does it fit into a different category? Learn more about Amazon.com Inc. and how to categorize it with MarketBeat. 
Via MarketBeat
What Are Dividend Payment Dates?
What are dividend payment dates? The payment date is the day a company pays its eligible shareholders dividends. Learn more. 
Via MarketBeat
Johnson & Johnson: Taking The Bull By The Horns?
Johnson & Johnson is rushing toward a patent cliff but a new shelf offering registration suggests itis gearing up for acquisitions. 
Via MarketBeat
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Regulatory
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
From Johnson & Johnson
Via Business Wire
Pain Relief Medication Market to Witness Huge Growth by Key Players: Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Plc.
Global Pain Relief Medication Market By Material (Acute, Chronic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) 
Via SBWire
MarketBeat Week in Review – 1/30 - 2/3
The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot 
Via MarketBeat
Topics Artificial Intelligence Earnings Economy
Exposures Artificial Intelligence Financial Interest Rates
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
From Johnson & Johnson
Via Business Wire
Liposome Drug Delivery Market 2023 in-Depth Analysis, Growth, Size, Future Prospect, Regional Development and Global Outlook 2029
Liposome Drug Delivery Market Size, Share and Forecast 2023-2029 Key Players are – Ipsen Pharma, Celsion Corp, Gilead Sciences, Astellas Pharma, Johnson & Johnson, Luye Pharma Group, Novartis AG 
Via SBWire
Exposures COVID-19
Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
SAN DIEGO, February 1, 2023 (Newswire.com) - On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium,... 
Via Newswire.com
How Do Lawsuits Affect Johnson & Johnson's Stock Price?
JNJ's stock price was hit hard on Monday following the court's ruling for billions of dollars worth of lawsuits - what does this mean for investors? 
Via MarketBeat
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Osteotomy Plates Market Share with Top Countries Data, Size, Global Industry Challenges, Business Overview and Forecast Research Study 2028
Osteotomy Plates SWOT Analysis Including Key Players - Arthrex, Acumed, Medartis, Johnson & Johnson, Group Fh Ortho, B. Braun Melsungen, Zimmer Biomet, Stryker Corporation, aap Implantate, Wright... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate. 
Via MarketBeat
Topics Workforce
Exposures Layoff Product Safety
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
From Johnson & Johnson
Via Business Wire
MarketBeat Week in Review – 1/16 - 1/20
The shortened trading week looks to be ending on a sour note over growing recession fears. Here are some of the top stories from our MarketBeat contributors 
Via MarketBeat
Topics Economy Workforce
Exposures Economy Layoff
AbbVie Stock: Dividend King ABBV Overview
Via MarketBeat
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
From Johnson & Johnson
Via Business Wire
Drug Delivery Market – Major Technology Giants in Buzz Again : Johnson & Johnson, Sanofi, Pfizer
How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Drug Delivery Market. 
Via SBWire
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week. 
Via MarketBeat
Topics Stocks
Exposures US Equities
3 Dividend Stocks For Passive Income
I'm aiming to grow my passive income this year through adding these safe value stocks to my portfolio that have strong dividend yields. 
Via MarketBeat
Topics Economy
Exposures Economy
Financial Resources Federal Credit Union Taps Scienaptic's Platform to Power its Credit Decisions With AI
NEW YORK - Jan. 11, 2023 - PRLog -- Leading global AI-powered credit decision platform provider, Scienaptic AI, announced today that Financial Resources Federal Credit Union has chosen to implement its... 
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence
These Steelmakers Deserve A Place On Your 2023 Watch List
Steel stocks including Nucor and Steel Dynamics are bringing holiday cheer to investors as they have potential to benefit from infrastructure spending in 2023. 
Via MarketBeat
Johnson & Johnson Completes Acquisition of Abiomed
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
From Johnson & Johnson
Via Business Wire
Two Blue Chip Health Companies The Institutions Are Buying
Johnson & Johnson and Abbott Laboratories are two Dividend Kings the analysts are buying, one stock is ready to rebound and the other to lead the market. 
Via MarketBeat
MarketBeat: Week in Review 12/05 – 12/09
The markets continue to have a lot to digest before there can be a Santa Claus raly. Here are some of the top stories our analysts were covering this week. 
Via MarketBeat
Topics Economy Electric Vehicles Supply Chain
Exposures Electric Vehicles Interest Rates Supply Chain
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.